256 related articles for article (PubMed ID: 21918474)
1. Algorithms to measure carotid intima-media thickness in trials: a comparison of reproducibility, rate of progression and treatment effect.
Dogan S; Plantinga Y; Crouse JR; Evans GW; Raichlen JS; O'Leary DH; Palmer MK; Grobbee DE; Bots ML;
J Hypertens; 2011 Nov; 29(11):2181-93. PubMed ID: 21918474
[TBL] [Abstract][Full Text] [Related]
2. Ultrasound protocols to measure carotid intima-media thickness in trials; comparison of reproducibility, rate of progression, and effect of intervention in subjects with familial hypercholesterolemia and subjects with mixed dyslipidemia.
Dogan S; Duivenvoorden R; Grobbee DE; Kastelein JJ; Shear CL; Evans GW; Visseren FL; Bots ML;
Ann Med; 2010 Sep; 42(6):447-64. PubMed ID: 20645885
[TBL] [Abstract][Full Text] [Related]
3. Extensive or restricted ultrasound protocols to measure carotid intima-media thickness: analysis of completeness rates and impact on observed rates of change over time.
Peters SA; den Ruijter HM; Palmer MK; Grobbee DE; Crouse JR; O'Leary DH; Evans GW; Raichlen JS; Bots ML;
J Am Soc Echocardiogr; 2012 Jan; 25(1):91-100. PubMed ID: 21982737
[TBL] [Abstract][Full Text] [Related]
4. Does baseline carotid intima-media thickness modify the effect of rosuvastatin when compared with placebo on carotid intima-media thickness progression? The METEOR study.
Crouse JR; Bots ML; Evans GW; Palmer MK; O'Leary DH; Grobbee DE; Raichlen JS;
Eur J Cardiovasc Prev Rehabil; 2010 Apr; 17(2):223-9. PubMed ID: 20038840
[TBL] [Abstract][Full Text] [Related]
5. C-reactive protein lowering with rosuvastatin in the METEOR study.
Peters SA; Palmer MK; Grobbee DE; Crouse JR; O'Leary DH; Raichlen JS; Bots ML
J Intern Med; 2010 Aug; 268(2):155-61. PubMed ID: 20412373
[TBL] [Abstract][Full Text] [Related]
6. Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial.
Crouse JR; Raichlen JS; Riley WA; Evans GW; Palmer MK; O'Leary DH; Grobbee DE; Bots ML;
JAMA; 2007 Mar; 297(12):1344-53. PubMed ID: 17384434
[TBL] [Abstract][Full Text] [Related]
7. Ultrasound protocols to measure carotid intima-media thickness: a post-hoc analysis of the OPAL study.
Dogan S; Plantinga Y; Evans GW; Meijer R; Grobbee DE; Bots ML;
Curr Med Res Opin; 2009 Jan; 25(1):109-22. PubMed ID: 19210144
[TBL] [Abstract][Full Text] [Related]
8. Biologically implausible carotid intima-media thickness measurement values: effects on rate of change over time.
Peters SA; den Ruijter HM; Palmer MK; Grobbee DE; Crouse JR; O'Leary DH; Evans GW; Raichlen JS; Bots ML;
Curr Med Res Opin; 2012 Jun; 28(6):891-9. PubMed ID: 22536884
[TBL] [Abstract][Full Text] [Related]
9. Intensive lipid lowering may reduce progression of carotid atherosclerosis within 12 months of treatment: the METEOR study.
Bots ML; Palmer MK; Dogan S; Plantinga Y; Raichlen JS; Evans GW; O'Leary DH; Grobbee DE; Crouse JR;
J Intern Med; 2009 Jun; 265(6):698-707. PubMed ID: 19298496
[TBL] [Abstract][Full Text] [Related]
10. Manual or semi-automated edge detection of the maximal far wall common carotid intima-media thickness: a direct comparison.
Peters SA; den Ruijter HM; Palmer MK; Grobbee DE; Crouse JR; O'Leary DH; Evans GW; Raichlen JS; Lind L; Bots ML;
J Intern Med; 2012 Mar; 271(3):247-56. PubMed ID: 21726301
[TBL] [Abstract][Full Text] [Related]
11. One-year treatment with rosuvastatin reduces intima-media thickness in 45 hypercholesterolemic subjects with asymptomatic carotid artery disease.
Riccioni G; Vitulano N; Mancini B; Zanasi A; D'Orazio N
Pharmacology; 2010; 85(2):63-7. PubMed ID: 20110750
[TBL] [Abstract][Full Text] [Related]
12. Carotid intima-media thickness in low-risk individuals with asymptomatic atherosclerosis: baseline data from the METEOR study.
Crouse JR; Grobbee DE; O'Leary DH; Bots ML; Evans GW; Palmer MK; Riley WA; Raichlen JS;
Curr Med Res Opin; 2007 Mar; 23(3):641-8. PubMed ID: 17355745
[TBL] [Abstract][Full Text] [Related]
13. Effects of consumption of pomegranate juice on carotid intima-media thickness in men and women at moderate risk for coronary heart disease.
Davidson MH; Maki KC; Dicklin MR; Feinstein SB; Witchger M; Bell M; McGuire DK; Provost JC; Liker H; Aviram M
Am J Cardiol; 2009 Oct; 104(7):936-42. PubMed ID: 19766760
[TBL] [Abstract][Full Text] [Related]
14. Rosuvastatin Slows Progression of Carotid Intima-Media Thickness: The METEOR-China Randomized Controlled Study.
Zheng H; Li H; Wang Y; Li Z; Hu B; Li X; Fu L; Hu H; Nie Z; Zhao B; Wei D; Karlson BW; Bots ML; Meng X; Chen Y; Wang Y;
Stroke; 2022 Oct; 53(10):3004-3013. PubMed ID: 36017704
[TBL] [Abstract][Full Text] [Related]
15. Effects of sources of variability on sample sizes required for RCTs, applied to trials of lipid-altering therapies on carotid artery intima-media thickness.
Gould AL; Koglin J; Bain RP; Pinto CA; Mitchel YB; Pasternak RC; Sapre A
Clin Trials; 2009 Aug; 6(4):305-19. PubMed ID: 19667027
[TBL] [Abstract][Full Text] [Related]
16. The effect of tibolone and continuous combined conjugated equine oestrogens plus medroxyprogesterone acetate on progression of carotid intima-media thickness: the Osteoporosis Prevention and Arterial effects of tiboLone (OPAL) study.
Bots ML; Evans GW; Riley W; McBride KH; Paskett ED; Helmond FA; Grobbee DE;
Eur Heart J; 2006 Mar; 27(6):746-55. PubMed ID: 16415304
[TBL] [Abstract][Full Text] [Related]
17. Increased high-density lipoprotein cholesterol predicts the pioglitazone-mediated reduction of carotid intima-media thickness progression in patients with type 2 diabetes mellitus.
Davidson M; Meyer PM; Haffner S; Feinstein S; D'Agostino R; Kondos GT; Perez A; Chen Z; Mazzone T
Circulation; 2008 Apr; 117(16):2123-30. PubMed ID: 18413496
[TBL] [Abstract][Full Text] [Related]
18. Effect of number of ultrasound examinations on the assessment of carotid intima-media thickness changes over time: the example of the METEOR study.
Peters SA; Palmer MK; Grobbee DE; Crouse JR; Evans GW; Raichlen JS; Bots ML;
J Hypertens; 2011 Jun; 29(6):1145-54. PubMed ID: 21546878
[TBL] [Abstract][Full Text] [Related]
19. Measuring Effects on intima media Thickness: an Evaluation Of Rosuvastatin in subclinical atherosclerosis--the rationale and methodology of the METEOR study.
Crouse JR; Grobbee DE; O'Leary DH; Bots ML; Evans GW; Palmer MK; Riley WA; Raichlen JS;
Cardiovasc Drugs Ther; 2004 May; 18(3):231-8. PubMed ID: 15229392
[TBL] [Abstract][Full Text] [Related]
20. Completeness of carotid intima media thickness measurements depends on body composition: the RADIANCE 1 and 2 trials.
Dogan S; Duivenvoorden R; Grobbee DE; Kastelein JJ; Shear CL; Evans GW; Visseren FL; Bots ML;
J Atheroscler Thromb; 2010 May; 17(5):526-35. PubMed ID: 20228610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
